A detailed history of Briaud Financial Planning, Inc transactions in Evotec Se stock. As of the latest transaction made, Briaud Financial Planning, Inc holds 2,160 shares of EVO stock, worth $9,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,160
Previous 2,160 -0.0%
Holding current value
$9,655
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$6.89 - $11.4 $14,882 - $24,624
2,160 New
2,160 $17,000
Q3 2023

Nov 03, 2023

BUY
$9.63 - $13.36 $20,800 - $28,857
2,160 New
2,160 $21,000

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.58B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Briaud Financial Planning, Inc Portfolio

Follow Briaud Financial Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Briaud Financial Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Briaud Financial Planning, Inc with notifications on news.